How to Optimize Female Hormone Health for Vitality and Longevity

Female hormone health is not just about estrogen, progesterone, or what happens during the reproductive years. It involves a conversation among the brain, ovaries, adrenal glands, thyroid, gut, and metabolic system. That conversation influences energy, sleep, mood, sexual function, and long-term health.

One of the most useful themes from my discussion with Dr. Sara Gottfried is that the right questions change across the lifespan. Irregular cycles in adolescence, elevated androgens in early adulthood, and sleep disruption during perimenopause offer different opportunities to understand what is happening.

The goal is not to measure everything or chase a supposedly perfect hormone number. It is to connect symptoms, family history, and appropriately chosen measurements so that health decisions become more individualized.

Table of Contents

• Start With Family History, Including Experiences Beyond Diagnoses
• Hormone Health by Decade: What Is Worth Paying Attention To?
• When to Test Hormones During the Menstrual Cycle
• Nutrition, Micronutrients, and the Gut
• Constipation Can Be a Clue, Not Just an Inconvenience
• Reduce Perceived Stress With a Menu of Tools
• PCOS Is a Lifelong Metabolic Issue, Not Only a Fertility Issue
• Continuous Glucose Monitors: Feedback That Can Change Behavior
• Match Exercise to Your Physiology and Recovery
• Oral Contraceptives: Consider Benefits and Tradeoffs Together
• Perimenopause Is Also a Brain and Metabolic Transition
• Cardiovascular Risk Belongs in the Hormone Health Conversation

Start With Family History, Including Experiences Beyond Diagnoses

Conversations with mothers and grandmothers can reveal important patterns. Gottfried highlights endometriosis, uterine fibroids, and polycystic ovary syndrome, or PCOS, as conditions with familial components.

But her approach goes beyond asking which diseases relatives developed. She also asks about trauma, chronic stress, and the environments in which women lived. Those experiences can affect stress physiology, including signaling through cortisol and the hypothalamic-pituitary-adrenal axis.

This does not mean that a relative’s experience determines your future. It means that family history includes both biological susceptibility and environmental context.

Useful questions include:

• Did close relatives have very painful periods, fibroids, endometriosis, or difficulty becoming pregnant?
• Were irregular cycles, acne, or increased facial or body hair common?
• What was the experience of perimenopause and menopause?
• Is there a family history of premature heart disease, thyroid disease, or Alzheimer’s disease?
• Were there significant patterns of trauma or prolonged stress?

Hormone Health by Decade: What Is Worth Paying Attention To?

Adolescence: Establish Patterns Before Chasing Numbers

Menstrual cycles are often irregular when they first begin. The reproductive system is still maturing, so estrogen and progesterone measurements can vary substantially and may not provide a useful baseline.

Gottfried places particular emphasis on stress physiology during these years. She also points to elevated androgens as a potential early clue, especially when accompanied by unwanted hair growth, acne, or persistent menstrual irregularity.

The practical distinction is between normal developmental variability and a pattern that deserves evaluation. Hormonal contraception can also obscure the underlying cycle, which matters when interpreting symptoms and laboratory results.

The 20s and 30s: Build Context for Future Comparisons

Once cycles become more established, Gottfried finds it useful to develop a baseline of estrogen, progesterone, testosterone, and, when appropriate, DHEA and other measures of androgen activity.

Her interest is not simply whether each value falls inside a laboratory reference range. She considers how the hormones relate to one another, the timing of the sample, and the person’s symptoms. She also examines estrogen metabolites, because the pathways through which estrogen is processed can have different biological effects.

These are features of her precision-medicine practice, not a universal recommendation that every healthy woman needs extensive hormone or metabolite testing.

Testosterone deserves attention in women, too. It contributes to sexual function, muscle biology, and responses to resistance training. Gottfried also discusses its possible relationship to confidence and agency. She notes that testosterone can begin declining in early adulthood, although individual trajectories vary.

When asked about her preferred testosterone range, she described aiming toward the upper half of the laboratory’s normal range in her clinical practice. That is her treatment preference, not a universal target, and a number alone is not a reason to begin hormone treatment.

The 40s and Beyond: Expand the Focus

As perimenopause approaches, cycle changes, sleep, mood, metabolic health, and cardiovascular risk become increasingly important. Earlier measurements may provide context, but the relevant question remains: what information would change care now?

When to Test Hormones During the Menstrual Cycle

Hormone results are difficult to interpret without knowing when the sample was collected.

For someone with a regular 28-day cycle, Gottfried’s preferred single testing window is approximately day 21 or 22, about a week before the next expected period. This timing is particularly relevant when assessing progesterone during the luteal phase, after ovulation.

If cycles shorten, she may move testing earlier, to approximately day 19 or 20. With irregular cycles, fixed calendar dates become less useful.

The principle is more important than the date: testing should match the biological question and the person’s actual cycle. Day 21 is not the correct testing day for everyone.

Gottfried prefers dried urine testing when she wants information about hormone metabolites in addition to hormone levels. Blood testing is generally less expensive and more commonly covered by insurance. Neither approach should be interpreted outside the context of symptoms, cycle timing, and the reason for testing.

Nutrition, Micronutrients, and the Gut

Hormone production and metabolism depend on adequate nutrition. Gottfried therefore often includes nutritional assessment early in her evaluation rather than treating it as an afterthought.

Depending on the clinical situation, her testing may include:

• B vitamins: Including folate and vitamin B12, with attention to factors that may affect their availability or metabolism.
• Antioxidant-related measures: Such as vitamins A and C and glutathione.
• Minerals: Particularly magnesium, which participates in many physiological processes, including pathways involved in hormone metabolism.

She uses a combination of blood and urine measurements and favors red blood cell magnesium when evaluating magnesium status in her practice. The value of a particular test depends on the question being asked; an extensive panel is not automatically more useful than a targeted evaluation.

She also emphasizes vegetable intake and plant compounds such as polyphenols, including during adolescence. Her larger point is that nutrition early in life can matter for health much later, even when the benefits feel remote to a teenager.

A Practical Option for People Who Dislike Vegetables

Sometimes the barrier is not a lack of information. It is taste.

One strategy Gottfried uses is a smoothie several times per week. Steamed broccoli that has been frozen can blend into a chocolate-flavored smoothie with relatively little taste. Greens can also be combined with berries and vanilla.

She considers greens powders convenient, but places supplements behind a food-based strategy. The objective is to make a more varied diet achievable, not to turn every meal into a supplement protocol.

The microbiome is another part of her assessment. She is interested in stool patterns and gut function alongside hormones and nutrient status. Importantly, a nutritional blood panel and a microbiome test answer different questions; neither substitutes for understanding symptoms and diet.

Constipation Can Be a Clue, Not Just an Inconvenience

Gottfried reports that constipation is common among the women she treats. Her approach is to consider several interacting contributors rather than assume there is one explanation.

These include thyroid function, stress physiology, diet, and changes in reproductive hormones. Hypothyroidism can contribute to constipation, and persistent symptoms warrant appropriate evaluation rather than an automatic recommendation to take more supplements.

She also emphasizes the relationship among psychological experience, immune signaling, nervous system activity, and endocrine function. Trauma and perceived stress are part of that picture, although her interpretation of “holding things in” is a clinical perspective rather than an established explanation for constipation.

The useful takeaway is to notice bowel frequency and changes over time, and to consider them alongside the rest of your health.

Reduce Perceived Stress With a Menu of Tools

Gottfried makes an important distinction between eliminating stress and changing perceived stress: how demanding or threatening an experience feels, and how well equipped you feel to handle it.

Most people cannot remove every deadline, caregiving responsibility, or difficult event. They can, however, develop tools that change their response.

Her preferred model is an individualized menu rather than a single prescription. Options discussed include:

• Meditation, including transcendental meditation.
• Yoga.
• Breathwork, with the recognition that practices vary considerably in intensity.
• Sexual intimacy and orgasm.
• Connection and the experience of feeling heard, understood, and loved.

What helps at one stage of life may not be the best fit at another. A practice should be evaluated by its effects on sleep, recovery, mood, and daily functioning, not simply by whether it is popular.

PCOS Is a Lifelong Metabolic Issue, Not Only a Fertility Issue

PCOS often comes to attention because of irregular periods, unwanted hair growth, acne, or difficulty becoming pregnant. But limiting it to reproductive health misses a major part of the condition.

The diagnostic features discussed include:

• Irregular or infrequent ovulation, often reflected in long or unpredictable cycles.
• Clinical or biochemical evidence of elevated androgen activity.
• Polycystic ovarian morphology on imaging.

Diagnostic systems differ, and not everyone with PCOS has the ovarian appearance suggested by its name. In adults, cycles longer than approximately 35 days can be one clue. Hirsutism refers to increased coarse hair growth in an androgen-associated pattern, such as on the face or chest.

For a fuller clinical explanation, the National Institute of Child Health and Human Development’s PCOS resource provides supporting context.

Gottfried’s central point is that PCOS remains relevant after the reproductive years. Elevated androgens, insulin resistance, and related metabolic changes can influence cardiometabolic health as women age.

How Insulin Can Drive Androgen Production

In some PCOS phenotypes, elevated insulin stimulates ovarian theca cells to produce more testosterone. This is one reason glucose and insulin deserve attention alongside reproductive hormones.

It also explains why a normal glucose reading does not necessarily answer every metabolic question. Insulin can rise before glucose becomes clearly abnormal.

Continuous Glucose Monitors: Feedback That Can Change Behavior

Gottfried is enthusiastic about continuous glucose monitors, or CGMs, because they make the effects of meals, movement, and daily routines visible. She finds that this feedback can change behavior in ways that abstract advice often does not.

She also emphasizes a limitation: glucose is only part of the picture. Insulin measurements may identify changes that are not yet obvious from glucose alone.

The broader principle is access to understandable health information. When people can see and interpret their own data, they can participate more actively in care.

That does not mean every fluctuation requires correction or that everyone needs a CGM. More data are useful when they support a meaningful decision, not when they simply create more numbers to worry about.

Match Exercise to Your Physiology and Recovery

When asked about vitality and longevity, Gottfried identified several areas that can undermine health: inadequate sleep, alcohol, high perceived stress, unsuitable eating patterns, toxic relationships, isolation, and insufficient or poorly matched movement.

Exercise illustrates her preference for individualized care.

Someone with substantial insulin resistance may benefit from more movement to help manage glucose. Someone already exhausted and under-recovered may not benefit from adding more strenuous endurance work.

Gottfried described reaching this realization in her own mid-30s. Despite running regularly, she experienced profound fatigue, abdominal weight gain, and low sexual desire. Her evaluation showed elevated cortisol and insulin, mildly abnormal thyroid measures, and low progesterone.

She shifted toward Pilates and yoga while changing how she managed stress. Her account is an individual clinical experience, not evidence that running is inherently harmful.

She also discussed vitamin C as a possible modifier of exercise-related cortisol responses. That should not obscure the main point: a supplement is not a substitute for adjusting training and recovery when the overall program is not serving you.

The useful question is not “Is cardio good or bad?” It is “Does this combination of endurance work, resistance training, and recovery fit my current physiology?”

Oral Contraceptives: Consider Benefits and Tradeoffs Together

Hormonal contraception provides reproductive choice, a benefit Gottfried considers essential. It can also be prescribed for symptoms such as acne or painful periods. A balanced discussion needs to include both its value and its possible adverse effects.

Ovarian Cancer Risk Reduction

One established benefit of oral contraceptive use is a lower risk of ovarian cancer. Gottfried discussed an approximately 50% reduction associated with several years of use, while the exact estimate depends on duration and the population studied.

The National Cancer Institute’s review of oral contraceptives and cancer risk explains this association alongside other cancer-related considerations.

Suppressing ovulation is relevant to this protective effect. However, ovarian cancer risk reduction alone does not determine whether a particular contraceptive is appropriate for a particular person.

Ovarian Cancer Symptoms Are Often Nonspecific

Bloating, lower abdominal fullness, and a sense of pressure can occur with ovarian cancer, but they also occur with many common, noncancerous conditions.

That overlap is one reason early detection is difficult. Persistent or changing symptoms deserve clinical attention rather than dismissal.

Ultrasound and the blood marker CA-125 may be used when evaluating a concerning finding or in selected higher-risk situations. They are not reliable general screening tools for everyone. Routine gynecologic care should not be confused with a test that reliably detects ovarian cancer early.

SHBG, Free Testosterone, and Sexual Symptoms

A mechanism Gottfried emphasizes is the increase in sex hormone-binding globulin, or SHBG, associated with oral estrogen. SHBG binds sex hormones, reducing the freely available fraction, including free testosterone.

Women differ in how they experience that change. Some notice little difference. Others report reduced sexual desire, vaginal dryness, or other changes in sexual function.

Gottfried also raises concerns about nutrient status, inflammatory markers, possible microbiome effects, and changes in stress-axis regulation. These findings vary in strength and do not mean that every person using oral contraception experiences clinically important harm.

She is particularly cautious about synthetic progestins. However, concerns arising from the Women’s Health Initiative cannot simply be applied to every contraceptive formulation: menopausal hormone therapy and contraceptive regimens involve different populations, doses, and treatment contexts.

What About Changes in Genital Tissue?

Gottfried cited limited research reporting reductions in clitoral measurements of up to about 20% with a studied oral contraceptive regimen. This is a striking finding, but it should not be presented as an expected effect of all birth control pills.

She also noted research in which SHBG remained elevated after discontinuation, while acknowledging uncertainty about reversibility and its clinical implications.

The practical response is informed consent and attention to symptoms, not a blanket instruction to stop contraception. Any change should account for pregnancy prevention and the reason the medication was prescribed.

Treat Painful Periods as Information

When contraception is prescribed mainly for painful periods or acne, Gottfried wants the underlying problem evaluated rather than automatically suppressed.

For menstrual pain, she discussed approaches directed at inflammation, including fish oil, specialized pro-resolving mediators, and anti-inflammatory medication. These are options she considers in practice, not interchangeable remedies appropriate for everyone.

The larger point is to ask why symptoms are occurring and what the available treatment choices are. Severe menstrual pain should not be normalized.

Perimenopause Is Also a Brain and Metabolic Transition

Perimenopause is the transition leading up to the final menstrual period. It can unfold over years and may begin with cycles becoming closer together, more anxiety, or difficulty sleeping.

Gottfried argues that these changes deserve attention before periods stop completely. Knowing an earlier hormonal and symptom baseline may help, but symptoms and clinical context remain central.

Changes in Brain Energy Metabolism

We discussed research by Lisa Mosconi examining brain metabolism across the menopause transition. Imaging studies have identified changes in cerebral glucose metabolism, with Gottfried describing an average reduction of roughly 20% in the comparisons she referenced.

Her phrase for the subjective experience is “slow brain energy”: entering a room and forgetting why, finding multitasking harder, or feeling less mentally efficient than before.

These findings do not mean that ordinary menopausal brain fog is dementia or that menopause inevitably leads to Alzheimer’s disease. They do support taking midlife brain health seriously rather than treating it as a concern that begins only in old age.

Estrogen signaling, insulin sensitivity, sleep, and the brain’s energy demands all belong in that conversation.

Hot Flashes and Night Sweats Are Not Trivial

Gottfried objects to dismissing hot flashes and night sweats as minor inconveniences. They can disrupt sleep substantially, and research has associated vasomotor symptoms with measures of cardiovascular, bone, and brain health.

An association is not the same as a diagnosis or a prediction for an individual. But the symptoms deserve a thoughtful assessment.

She advocates discussing hormone therapy more broadly than only asking whether hot flashes are intolerable. At the same time, menopausal hormone therapy should not be presented as a proven way to prevent Alzheimer’s disease. Decisions require an individualized discussion of symptoms, age, medical history, formulation, and potential benefits and risks.

Cardiovascular Risk Belongs in the Hormone Health Conversation

Gottfried’s closing recommendation was to consider a coronary artery calcium score, or CAC score, by age 45, and earlier when premature heart disease raises concern.

A CAC scan is a CT scan that measures calcified plaque in the coronary arteries. She sees it as a potential decision point: evidence that can prompt more focused attention to cardiometabolic health.

Her proposed timing is more proactive than routine screening for every asymptomatic woman. Whether the scan is useful should be discussed in the context of overall risk and whether its result would change management. A score of zero is reassuring in some settings, but it does not eliminate cardiovascular risk.

This brings the discussion back to its central theme. Female hormone health is connected to cardiovascular health, metabolism, brain function, sleep, and everyday quality of life. The most productive approach is to combine family history, symptoms, daily habits, and carefully selected measurements, then use that information to make decisions that fit the individual.